Literature DB >> 21425255

D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD.

Ekambaram Ganapathy1, Feng Su, David Meriwether, Asokan Devarajan, Victor Grijalva, Feng Gao, Arnab Chattopadhyay, G M Anantharamaiah, Mohamad Navab, Alan M Fogelman, Srinivasa T Reddy, Robin Farias-Eisner.   

Abstract

We recently reported that apoA-I and apoA-I mimetic peptides prevent the development of flank tumors in immunocompetent C57BL/6J mice. To delineate the mechanism(s) of action of apoA-I mimetic peptides in tumor development, we examined the effect of D-4F (an apoA-I mimetic peptide) on the antioxidant status and on the gene expression and function of antioxidant enzymes in ID8 cells (a mouse epithelial ovarian cancer cell line) and in a mouse model. We demonstrate that D-4F treatment significantly reduces the viability and proliferation of ID8 cells, with a concomitant improvement of the antioxidant status of ID8 cells as measured by lipid peroxidation, protein carbonyl, superoxide anion, and hydrogen peroxide levels. D-4F treatment induces MnSOD (but not CuZnSOD) mRNA, protein, and activity. Inhibition of MnSOD in ID8 cells using shRNA vectors abrogates the inhibitory effects of D-4F on ID8 cell viability and proliferation. Moreover, tumor development from ID8 cells carrying shRNA for MnSOD were unaffected by D-4F treatment. Our results suggest that the inhibitory effects of D-4F on ID8 cell proliferation and tumor development are mediated, at least in part, by the induced expression and activity of MnSOD.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21425255      PMCID: PMC3248802          DOI: 10.1002/ijc.26079

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  36 in total

1.  L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice.

Authors:  Satoshi Imaizumi; Victor Grijalva; Mohamad Navab; Brian J Van Lenten; Alan C Wagner; G M Anantharamiah; Alan M Fogelman; Srinivasa T Reddy
Journal:  Drug Metab Lett       Date:  2010-08

2.  Apolipoprotein A-I-mimetic peptides with antioxidant actions.

Authors:  Su Duy Nguyen; Tae-Sook Jeong; Dai-Eun Sok
Journal:  Arch Biochem Biophys       Date:  2006-05-06       Impact factor: 4.013

Review 3.  Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis.

Authors:  Courtney B Sherman; Stephen J Peterson; William H Frishman
Journal:  Cardiol Rev       Date:  2010 May-Jun       Impact factor: 2.644

4.  Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes.

Authors:  Saadet Turkseven; Adam Kruger; Christopher J Mingone; Pawel Kaminski; Muneo Inaba; Luigi F Rodella; Susumu Ikehara; Michael S Wolin; Nader G Abraham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-04-08       Impact factor: 4.733

5.  Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach.

Authors:  Akiko Horiuchi; Kazuko Itoh; Motohiko Shimizu; Ikuko Nakai; Teruyuki Yamazaki; Kaoru Kimura; Akihiko Suzuki; Isao Shiozawa; Noritane Ueda; Ikuo Konishi
Journal:  Gynecol Oncol       Date:  2003-03       Impact factor: 5.482

6.  Increased oxidative stress created by adenoviral MnSOD or CuZnSOD plus BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) inhibits breast cancer cell growth.

Authors:  Christine J Weydert; Yuping Zhang; Wenqing Sun; Trent A Waugh; Melissa L T Teoh; Kelly K Andringa; Nukhet Aykin-Burns; Douglas R Spitz; Brian J Smith; Larry W Oberley
Journal:  Free Radic Biol Med       Date:  2007-11-28       Impact factor: 7.376

7.  Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.

Authors:  R M Lebovitz; H Zhang; H Vogel; J Cartwright; L Dionne; N Lu; S Huang; M M Matzuk
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

8.  Proapoptotic and redox state-related signaling of reactive oxygen species generated by transformed fibroblasts.

Authors:  Mareike Schimmel; Georg Bauer
Journal:  Oncogene       Date:  2002-08-29       Impact factor: 9.867

9.  Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients.

Authors:  Leanne T Bloedon; Richard Dunbar; Danielle Duffy; Paula Pinell-Salles; Robert Norris; Bruce J DeGroot; Rajesh Movva; Mohamad Navab; Alan M Fogelman; Daniel J Rader
Journal:  J Lipid Res       Date:  2008-03-06       Impact factor: 5.922

Review 10.  Reactive oxygen species in oncogenic transformation.

Authors:  L Behrend; G Henderson; R M Zwacka
Journal:  Biochem Soc Trans       Date:  2003-12       Impact factor: 5.407

View more
  24 in total

1.  Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1α in human ovarian cancer cell lines and a mouse ovarian cancer model.

Authors:  Feng Gao; Arnab Chattopadhyay; Mohamad Navab; Victor Grijalva; Feng Su; Alan M Fogelman; Srinivasa T Reddy; Robin Farias-Eisner
Journal:  J Pharmacol Exp Ther       Date:  2012-04-25       Impact factor: 4.030

Review 2.  Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins.

Authors:  Satoshi Imaizumi; Mohamad Navab; Cecilia Morgantini; Christina Charles-Schoeman; Feng Su; Feng Gao; Murray Kwon; Ekambaram Ganapathy; David Meriwether; Robin Farias-Eisner; Alan M Fogelman; Srinivasa T Reddy
Journal:  Circ J       Date:  2011-05-28       Impact factor: 2.993

3.  HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer.

Authors:  Feng Su; Victor Grijalva; Kaveh Navab; Ekambaram Ganapathy; David Meriwether; Satoshi Imaizumi; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy; Robin Farias-Eisner
Journal:  Mol Cancer Ther       Date:  2012-03-13       Impact factor: 6.261

Review 4.  Manganese superoxide dismutase in cancer prevention.

Authors:  Delira Robbins; Yunfeng Zhao
Journal:  Antioxid Redox Signal       Date:  2013-07-18       Impact factor: 8.401

5.  The potential of apolipoprotein mimetic peptides in the treatment of atherosclerosis.

Authors:  Luke J Leman
Journal:  Clin Lipidol       Date:  2015-06

Review 6.  Apolipoprotein A-I mimetics.

Authors:  Srinivasa T Reddy; Mohamad Navab; Gattadahalli M Anantharamaiah; Alan M Fogelman
Journal:  Curr Opin Lipidol       Date:  2014-08       Impact factor: 4.776

7.  Macrophage scavenger receptor a promotes tumor progression in murine models of ovarian and pancreatic cancer.

Authors:  Claudine Neyen; Annette Plüddemann; Subhankar Mukhopadhyay; Eleni Maniati; Maud Bossard; Siamon Gordon; Thorsten Hagemann
Journal:  J Immunol       Date:  2013-02-27       Impact factor: 5.422

8.  Prognostic and Therapeutic Value of Apolipoprotein A and a New Risk Scoring System Based on Apolipoprotein A and Adenosine Deaminase in Chronic Lymphocytic Leukemia.

Authors:  Xiaoya Yun; Xiang Sun; Xinting Hu; Huimin Zhang; Zixun Yin; Xin Zhang; Ming Liu; Ya Zhang; Xin Wang
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

9.  High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia.

Authors:  Ching-Hung Lin; Ruby Yun-Ju Huang; Tzu-Pin Lu; Kuan-Ting Kuo; Ko-Yun Lo; Ching-Hsuan Chen; I-Chun Chen; Yen-Shen Lu; Eric Y Chuang; Jean Paul Thiery; Chiun-Sheng Huang; Ann-Lii Cheng
Journal:  NPJ Breast Cancer       Date:  2021-07-05

10.  Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles.

Authors:  Ying Zheng; Yanyan Liu; Honglin Jin; Shaotao Pan; Yuan Qian; Chuan Huang; Yixin Zeng; Qingming Luo; Musheng Zeng; Zhihong Zhang
Journal:  Theranostics       Date:  2013-06-25       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.